Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Pfizer's new antifungal agents

Feb. 27, 1997

Favorable results reported for Mentax

Feb. 26, 1997

Recurrent herpes treatment development advances

Feb. 26, 1997

Zanamivir enters pivotal trials

Feb. 26, 1997

Antiherpesvirus agents reported by Bio-Mega/Boehringer Ingelheim

Feb. 25, 1997

Antiviral nucleoside analogues available for licensing

Feb. 24, 1997

Alpha-Beta/MycoTox antifungal collaboration

Feb. 21, 1997

New agreement reached for Searle's Maxaquin

Feb. 20, 1997

Antifungals from Schering-Plough

Feb. 20, 1997

U.S. researchers prepare chloroquine analogues

Feb. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...